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Introduction
Rwanda established the National Center for Blood Trans-
fusion (NCBT) with the mission to provide safe, effective,
and adequate blood and blood products to all patients in
need. This is done by collecting blood exclusively from
low risk VNRBD and tests each sample for TTIs by using
QMS. This paper showcases NCBT operations in ensuring
safe blood and blood products.
Methods
The NCBT has implemented strategies based on QMS for
NRVBD safety (questionnaire, clinical exams, etc), testing
using automate machine (immuno-hematology and serol-
ogy), using BECS to manage individual record, and devel-
oped national guidelines for rational use of blood in
hospital, therefore extending NCBT safety procedures
from vein to vein.
Results
Routine data of NCBT shows the following: New donors
(38.5%, 30.5%), irregular Donors (11.4%, 18.1%), regular
donor (50.1%, 51.4%) respectively 2011 and 2012.
The serology results from initial testing shows that in
2011 among 37811 blood donors, 203 (0.54%) were HIV
reactive, 609 (1.61%) HBV reactive, 1113(2.94%) HCV
reactive and 668 (1.77%) were Syphilis reactive. In 2012
among 40520 blood donors recruited 203(0.50%) were
HIV positive, 616 (1.52%) HBV positive, 1146(2.83%) HCV
positive and 628 (1.55%) were syphilis positive.
Conclusion
The result shows an increase of blood collected and a
decrease of TTIs results in the last 2 years. This is asso-
ciated to strategies implemented by NCBT on blood
donor selection and quality testing through corrective
and preventive action to reduce to the lowest level the
risk of infectious agent.
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